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Stijn I Blot1,2*, Jan Poelaert3 and Marin Kollef4Abstract
Microaspiration of subglottic secretions through channels formed by folds in high volume-low pressure poly-vinyl
chloride cuffs of endotracheal tubes is considered a significant pathogenic mechanism of ventilator-associated
pneumonia (VAP). Therefore a series of prevention measures target the avoidance of microaspiration. However,
although some of these can minimize microaspiration, benefits in terms of VAP prevention are not always obvious.
Polyurethane-cuffed endotracheal tubes successfully reduce microaspiration but high quality data demonstrating
VAP rate reduction are lacking. An analogous conclusion can be made regarding taper-shaped cuffs compared with
classic barrel-shaped cuffs. More clinical data regarding these endotracheal tube designs are needed to demonstrate
clinical value in addition to in vitro-based evidence. The clinical usefulness of endotracheal tubes developed for
subglottic secretions drainage is established in multiple studies and confirmed by meta-analysis. Any change in
cuff design will fail to prevent microaspiration if the cuff is insufficiently inflated. At least one well-designed trial
demonstrated that continuous cuff pressure monitoring and control decrease the risk of VAP. Gel lubrication of
the cuff prior to intubation temporarily hampers microaspiration through sludging the channels formed by folds
in high volume-low pressure cuffs. As the beneficial effect of gel lubrication is temporarily, its potential to reduce VAP
risk is probably nonsignificant. A minimum positive end-expiratory pressure of at least 5 cmH2O can be recommended
as it reduces the risk of microaspiration in vitro and in vivo. One randomized controlled study demonstrated a reduced
risk of VAP in patients ventilated with PEEP (5–8 cmH2O). Regarding head-of-bed elevation, it can be recommended to
avoid supine positioning. Whether a 45° head-of-bed elevation is to be preferred above 25-30° head-of-bed elevation
remains unproven. Finally, the routine monitoring of gastric residual volumes in mechanically ventilated patients
receiving enteral nutrition cannot be recommended.
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Ventilator-associated pneumonia (VAP) remains a feared
complication in intensive care unit (ICU) and high-risk
surgical postoperative patients [1]. VAP is associated
with substantial excess morbidity [2-4] and may suppress
survival [5-9]. On average 10-20% of ICU patients venti-
lated for >2 days experience VAP [10]. However, VAP
incidence may vary according to diagnostic approach.
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marking [11]. Incidence estimates may also vary with
patients’ risk profile and compliance with prevention
measures, which remains an issue in many ICUs [12-16].
VAP prevention targets the main pathogenic mechan-
ism, which is bacterial translocation from stomach and
oropharynx to the lower respiratory tract. Within hours
following endotracheal intubation pathogenic microor-
ganisms colonize the oropharyngeal mucosal surfaces,
dental plaque, sinuses, and stomach [17,18]. Accumula-
tion of oropharyngeal secretions colonized with these
pathogens occurs above the endotracheal tube (ETT)
cuff. Microaspiration of these subglottic secretions might
occur through an underinflated tracheal cuff or through. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Furthermore, a nasogastric tube may facilitate gastro-
esophageal reflux. Therefore, gastric juice may be aspi-
rated into the lungs, provoking local inflammation
[17,19]. Generally, the prevention of VAP is focused on
reducing the exposure time, maintaining oral hygiene
by antiseptic rinsing, and avoidance of microaspiration
[20-22]. However, microaspiration seems decisive be-
cause it is unlikely that prolonged exposure or bad oral
hygiene as such would arouse VAP in the absence of
substantial microaspiration. Consequently, a lot of em-
phasis is given to avoidance or minimization of microas-
piration [22]. Several preventive measures have been
developed to decrease the risk of microaspiration. Al-
though some of these successfully reduced microaspiration,
their potential to reduce VAP is not always proven. The ob-
jective of this paper is to briefly review measures to avoid
microaspiration of subglottic secretions and to evaluate
their effectiveness in doing so and in preventing VAP.
Review
Selection of the endotracheal tube
In the 1960s cuffs of ETTs were made of red rubber.
While these “high pressure-low volume” cuffs were suc-
cessful in sealing the extraluminal airway, ischemic dam-
age of the tracheal wall was an issue. Therefore these
ETTs were soon replaced by ETTs with “high volume-
low pressure” (HVLP) cuffs made out of polyvinyl chloride
(PVC). In the past decades HVLP cuff ETTs experienced
several changes in design, some of them with the primary
aim to reduce the risk of microaspiration. Some of these
will be mentioned hereunder.
Endotracheal tube cuff material: polyurethane vs. PVC
One of the disadvantages of the standard HVLP cuff is
that the diameter of the cuff is bigger than the tracheal
diameter. As such, only a low pressure is needed for in-
flation and for letting the cuff adapt to the shape of the
trachea. With this concept, however, the cuff is not fully
unfolded resulting in channel formation along the cuff.
Through these channels microaspiration might occur.
Ultrathin polyurethane cuffs have been developed to
minimize the channel size within folds of an inflated
cuff. In an in vitro setup using a tracheal model with a
20 mm internal diameter, fluid leakage past the tube cuff
was compared between a polyurethane cuff (cuff mem-
brane thickness 7 μm) and four ETTs with a PVC cuff (cuff
membrane thickness 50 to 70 μm) [23]. Fluid leakage was
evaluated at cuff pressures of 10, 15, 20, 25, 30 and
60 cmH2O, and the amount of fluid leakage was recorded
at 5, 10, and 60 minutes. Within the recommended target
cuff pressure of 20–30 cmH2O, the polyurethane cuff was
the only to effectively prevent fluid leakage past the cuff. In
another in vitro study three types of polyurethane cuffedETTs were compared with three types of ETTs with a PVC
cuff [24]. The amount of fluid leakage after 1 hr was evalu-
ated in three artificial tracheal models varying in internal
diameter (16, 20, and 22 mm). Overall, polyurethane ETTs
prevented fluid leakage more efficiently than PVC cuffs
(p < 0.001). Similar observations were made in a bench-
top study in which tracheal models were exposed to differ-
ent levels of positive end-expiratory pressure (PEEP) [25].
Concerning clinical outcomes, the available data are
scarce. A polyurethane cuffed ETT significantly reduced
the risk of early post-operative pneumonia in high-risk
cardiac surgical patients from 42% to 23% (adjusted odds
ratio 0.31, 95% confidence interval [CI] 0.13–0.77) [26].
In a randomized controlled trial, Mahmoodpoor et al.
compared rates of VAP associated with three types of
ETTs: a cylindrical polyurethane cuffed, a taper-shaped
polyurethane cuffed, and a cylindrical PVC cuffed tube
[27]. In a comparison with polyurethane cuffed tubes
(both groups merged) and the PVC cuffed ETT, no dif-
ference in VAP could be observed (20% vs. 34%, respect-
ively; p = 0.134). However, this study suffers several
limitations. The study was likely to be underpowered
and VAP was defined solely in accordance with the clin-
ical pulmonary infection score thereby probably leading
to overestimation of the true incidence.
Endotracheal cuff shape: tapered vs. cylindrical
Conventional ETTs have a cylindrical-shaped cuff. An
ETT with a taper-shaped cuff was developed with the
promise to better adapt to natural variations in the size of
the trachea. Because of its tapered shape, this cuffs seals
the trachea, at least at one point, without fold formation.
An in-vitro study was able to demonstrate superior
sealing capacity of these taper-shaped cuffs compared to
cylindrical-shaped cuffs [24]. Additionally, they appeared
to be equally effective in preventing fluid leakage as
cylindrical-shaped polyurethane cuffed ETTs. Of note, in
tracheal models with a larger diameter the favorable effect
of taper-shaped cuffs over cylindrical-shaped polyurethane
cuffs was greater. In a clinical bronchoscopy-controlled
study in patients undergoing lumbar surgery, microaspira-
tion of instilled methylthionium chloride was compared
between taper-shaped PVC cuffs and barrel-shaped PVC
cuffs [28]. After 30 minutes, following turning the patients
in prone position, the barrel-shaped cuff showed descent
of dye into the trachea in 20% of the patients. Contrariwise,
after two hours of observation, no dye leakage into the tra-
chea was observed with taper-shaped cuffs. To what extent
the endotracheal tube with a taper-shaped cuff results in
reduced VAP rates remains to be demonstrated.
Subglottic secretions drainage (SSD)
Another strategy to prevent microaspiration is to avoid
accumulation of subglottic secretions above the cuff.
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dorsal lumen that opens directly above the cuff. A meta-
analysis pooling 13 randomized controlled trials and
encompassing 2442 patients demonstrated an overall risk
reduction with use of SSD of 0.55 (95% CI, 0.46-0.66)
[29]. When only high quality trials were taken into ac-
count the effect remained statistically significant (risk
ratio 0.54, 95% CI, 0.40-0.73). Overall, the use of SSD
was associated with a reduced ICU stay, decreased length
of ventilatory dependence, and an increased time to first
episode of VAP. Drainage can be successfully performed
either continuously or intermittently [30].
Gel lubrication of the cuff.
Gel lubrication of the cuff prior to intubation is mainly
done to smoothen the procedure. Yet, by doing so the
channels along the cuff wall are plugged thereby block-
ing microaspiration of oropharyngeal secretions. Blunt
et al. compared fluid leakage in lubricated and nonlubri-
cated cuffs in a benchtop model with use of a static pig
trachea model [31]. After 15 min. all five nonlubricated
cuffs leaked, while in none of the lubricated cuffs dye
leakage was observed. Another in vitro study testing six
different brands of ETTs revealed that in case of gel
lubrication no dye leakage occurred in the 1 hr observa-
tion period [32]. In all six nonlubricated cuffs leakage
became obvious within five minutes.
Microaspiration in lubricated vs. nonlubricated cuffs
was evaluated in a double-blinded, randomized clinical
study involving anesthetized patients undergoing extrac-
tion of wisdom teeth [31]. In all patients diluted blue
food dye was instilled above the cuff after intubation.
During the surgical procedure cuff pressure was main-
tained at 30cmH2O by a constant cuff pressure inflator.
Microaspiration was evaluated by means of endotracheal
aspiration after surgery and before extubation. Microas-
piration was witnessed in 11% of lubricated cuffs vs. 83%
of nonlubricated cuffs (p < 0.001). A similar approach of
blue dye instillation was used in a prospective observa-
tional study involving tracheotomized patients with lu-
bricated cuffs only [31]. The lubricated cuffs leaked after
a median period of 48 hrs (ranging 24 to 120 hrs). From
these studies it appears that microaspiration can be tem-
porarily avoided by gel lubrication. Therefore, gel lubrica-
tion might be of value in short term-ventilated patients.
However, any value in terms of pneumonia prevention
remains unproven.
Cuff pressure monitoring
No cuff seals when insufficiently inflated. The recom-
mended cuff pressure for HVLP cuffs ranges 20–30
cmH2O. However, cuff pressure easily deviates outside
this target interval due to pathophysiological and envir-
onmental circumstances, and body position changes[33,34]. Devices to provide automated monitoring and
adjustments of cuff pressure have been developed. In an
initial randomized controlled trial these devices proved
successful to maintain cuff pressure within the target
limits, but no effect on VAP rate was observed [35]. It
has been suggested that no difference in VAP rate was
observed as randomization took place two days following
intubation. In another randomized control trial, Nseir
et al. also demonstrated that continuous cuff pressure
monitoring was effective in maintaining the pressure
within the target limits compared with manual control
per 8 hours: 98% of measurements vs. 74% (p < 0.001)
[36]. In addition, patients in the intervention group had a
decreased risk for micro-aspiration of gastric contents
and VAP (9.8% vs. 26.2%; p = 0.032), thereby confining
the controversial status of continuous cuff pressure mon-
itoring as valuable to prevent pneumonia [37].
Positive End-Expiratory Pressure (PEEP)
Experimental studies with HVLP cuffs showed that, as
airway pressures rise, the gas contained within the cuff
is redistributed from the distal to the proximal cuff end.
This results in a cone-shaped cuff in which the intra-
cuff pressure is temporarily (during the inspiratory
phase) higher than the cuff pressure during the expira-
tory phase. As such, positive pressure ventilation creates
a ‘self-sealing’ effect by which tracheal occlusion is main-
tained despite airway pressure exceeding intra-cuff pres-
sures [38]. Therefore it was hypothesized that PEEP
could result in a better sealing capacity throughout the
ventilation cycle, and as such reduce micro-aspiration.
In a benchtop study Ouanes et al. demonstrated that
microaspiration occurring within one hour decreased
from 91% with zero PEEP to 8% with 15 cmH2O PEEP
[39]. Similarly, also Pitts et al. observed that micro-
aspiration decreased with higher levels of PEEP (5, 10 or
15 cmH2O) [40]. In this study peak inspiratory pressure
also was inversely associated with leakage volume but not
anymore when PEEP was set at 15 cmH2O. In vitro data
by Zanella also indicated that micro-aspiration did not
occur within 24 hrs when PEEP was set at 15 cmH2O, irre-
spective of which ETT type was investigated [25].
Lucangelo et al. evaluated the leakage of dye past the
cuff in a bronchoscopy-controlled study in ventilated
ICU patients [41]. The experiment lasted for 12 hrs. In
the first 5 hrs PEEP was maintained at 5 cmH2O; there-
after PEEP was removed. In two on 40 patients leakage
of dye occurred before removal of PEEP (5.0%). After
PEEP was removed, leakage became obvious in 37/40
patients (92.5%). A single center trial, non-hypoxic mech-
anically ventilated patients were randomized to receive
either 5–8 cmH20 PEEP (n = 66) or no PEEP (n = 65) [42].
VAP rate among patients ventilated with PEEP was 9.4%
and significantly lower compared with the control group
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patients in the intervention group experienced less hypox-
emia and there was no difference between the groups in
rates of acute respiratory distress syndrome, barotrauma,
or atelectasis. In the absence of particular contraindica-
tions, the use of at least 5 cmH2O of PEEP can be recom-
mended as standard in mechanically ventilated patients. In
patients with overt right ventricular failure however, safety
of external PEEP could be questioned. In these cases risks
and benefits should be carefully considered.
Semirecumbent position
In 1999 Draculovic reported a lower risk of clinically
suspected VAP (RR 0.23, 95% CI 0.07-0.72) and
microbiologically documented VAP (RR 0.22, 95% CI
0.05-0.93) among patients cared for in semirecumbent
positioning (45° head-of-bed elevation) compared to pa-
tients kept in supine position (0° head-of-bed elevation)
[43]. Especially patients in the supine group receiving en-
teral nutrition experienced a high risk of VAP. Another
randomized study comparing 45° vs. 25° head-of-bed ele-
vation found a nonsignificant reduction (RR 0.38, 95% CI
0.04-3.77) but the study was toughly underpowered (17 vs.
13 patients respectively) [44]. Both studies suffered several
limitations such as prematurely stopping after interim
analysis [43], high dropout rates [44], and uncertainties
about diagnostic approaches [43,44]. In the Draculovic
trial, correctness of patients’ position was checked once
daily, while Keeley et al. did not report posture checks.
This is a serious flaw. van Niewenhoven et al. conducted a
trial in which patients were randomly allocated to a 45° vs.
10° head-of-bed elevation [45]. Head-of-bed elevation was
continuously monitored by means of a transducer with
pendulum and a dedicated nurse controlled patients’ pos-
ition twice-to-thrice daily and restored to the target pos-
ition (if possible). As 85% of the time semirecumbent (45°)
positioning as not achieved, the study turned out to be a
comparison between approximately 10° vs. 28° head-of-
bed elevation. No difference in VAP risk was observed.
Although based on the results of a limited-quality trial,
most recommendations agree that supine positioning
is to be avoided [46]. However, it remains unproven
whether 45° head-of-bed elevation is superior to 25-30°
elevation. Despite the absence of a clear advantage, an
expert panel recommended semirecumbent positioning
weighting its potential benefits and harms [47]. Patients
at risk for hemodynamic instability following 45° head-
of-bed elevation may benefit from a 20-30° backrest
elevation [48].
Monitoring gastric overdistention
Gastric overdistention has been historically considered a
risk factor for VAP as it is assumed to facilitate bacterial
translocation from the stomach to the respiratory tract.With enteral nutrition becoming standard of care in
mechanically ventilated patients monitoring gastrointo-
lerance to enteral feeding by checking residual volumes
is frequent practice. Most frequent thresholds used to
interrupt enteral feeding are residual volumes of 200–
250 mL [49]. Yet, cessation of enteral feeding is not rec-
ommended unless residual volumes exceed 500 mL [50].
In addition, monitoring residual gastric volumes may in-
crease the risk of inadequate caloric intake. The effect of
not monitoring residual gastric volumes on risk of VAP
was evaluated in a multicentre, randomized controlled
trial [51]. VAP rate in the absence of monitoring residual
volumes was 16.7% and 15.8% in the control group in
which residual volumes were checked every 6 hrs (and
in which residual volumes greater than 250 mL were
returned to the patient) (difference, 0.9%, 90% CI, −4.8-
6.7%). No differences were observed between the groups
regarding rates of other healthcare-associated infections,
length of ventilator dependence, ICU stay, or mortality.
Importantly, the proportion of patients receiving 100%
of their caloric intake target was significantly higher in
the intervention group (odds ratio 1.77, 95% CI, 1.25-
2.51). As such, monitoring gastric overdistention seems
not to benefit prevention of VAP.
Interventions indirectly affecting the risk associated with
microaspiration
Some interventions do not directly target microaspira-
tion. Their practice however, may alter the risk of micro-
aspiration and/or pneumonia. Based on the available
evidence their use can be either be advocated or not.
Small bowel feedings, for example, are assumed to
minimize the risk of aspiration should intolerance to en-
teral feedings occur. No data however to support this
practice with the aim to reduce VAP risk are available.
Routine changes of ventilator circuits do not decrease
VAP risk. Even stronger, where no benefit is to be ex-
pected the patient may experience a microaspiration by
unnecessary manipulation of the tubings.
Mouthwashes with chlorhexidine solutions and se-
lective oral decontamination do not as such reduce
the risk of microaspiration [21,52]. Yet, these interven-
tions reduce the microbial burden in the oral cavity and
therefore the inoculum of potential pathogenic micro-
organisms entering the lower respiratory tract in case
of microaspiration.
Conclusions
Several interventions have been developed in order to
reduce the risk of microaspiration and subsequently
VAP. Taking into account the effectiveness of avoiding
microaspiration and VAP the following measures should
be considered: (i) the use of ETT designed for SSD,
(ii) continuous cuff pressure monitoring and control,
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supine positioning. The following measures lack data to
demonstrate their benefits in terms of VAP risk reduc-
tion, but are nevertheless interesting because of their
potential to reduce microaspiration: (i) gel lubrication of
the cuff prior to intubation, (ii) polyurethane cuffed
ETTs, and (iii) taper-shaped ETT cuffs.
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